Увійти

Готові списки джерел за темами / Diabetes mellitus and Peripheral vascular disease / Книги

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Diabetes mellitus and Peripheral vascular disease.

Книги з теми "Diabetes mellitus and Peripheral vascular disease"

Автор: Grafiati

Опубліковано: 3 червня 2025

Оновлено: 31 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-24 книг для дослідження на тему "Diabetes mellitus and Peripheral vascular disease".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте книги для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Shrikhande, Gautam V., and James F. McKinsey, eds. Diabetes and Peripheral Vascular Disease. Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-158-5.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

D, Kerstein Morris, ed. Diabetes and vascular disease. Lippincott, 1990.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Neil, Ruderman, Williamson Joseph, and Brownlee Michael, eds. Hyperglycemia, diabetes and vascular disease. O.U.P., 1992.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Jensen, Tonny. Albuminuria: A marker of renal and generalized vascular disease in insulin-dependent diabetes mellitus. Lægeforeningens Forlag, 1991.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

F, Keaney John, ed. Oxidative stress and vascular disease. Kluwer Academic Publishers, 1999.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Hans-Uwe, Janka, Mehnert H, Standl E, and International Workshop on Macrovascular Disease in Diabetes Mellitus : Pathogenesis and Prevention (1984 : Garmisch-Grainau, Germany), eds. Macrovascular disease in diabetes mellitus: Pathogenesis and prevention : international workshop, Garmisch-Grainau, October 1984. Georg Thieme, 1985.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Howarth, Vivienne. Is there a difference in assessment and management of Peripheral Vascular Disease (PVD) by specialist community and hospital podiatry staff in diabetes patients?: A pilot study. University of Surrey Roehampton, 2004.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Aristidis, Veves, Giurini John M, and LoGerfo Frank W, eds. The diabetic foot: Medical and surgical management. Humana Press, 2002.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Aristidis, Veves, Giurini John M, and LoGerfo Frank W, eds. The diabetic foot: Medical and surgical management. Humana Press, 2002.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Diabetes and Peripheral Vascular Disease Contemporary Diabetes. Humana Press, 2012.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Williamson, Joseph, Michael Brownlee, and Neil Ruderman. Hyperglycemia, Diabetes and Vascular Disease. Springer, 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

McKinsey, James F., and Gautam V. Shrikhande. Diabetes and Peripheral Vascular Disease: Diagnosis and Management. Humana Press, 2012.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

McKinsey, James F., and Gautam V. Shrikhande. Diabetes and Peripheral Vascular Disease: Diagnosis and Management. Humana, 2016.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

McKinsey, James F., and Gautam V. Shrikhande. Diabetes and Peripheral Vascular Disease: Diagnosis and Management. Humana Press, 2012.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Gnudi, Luigi, Giorgio Gentile, and Piero Ruggenenti. The patient with diabetes mellitus. Edited by Giuseppe Remuzzi. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0149_update_001.

Повний текст джерела

Анотація:

About one third of patients with type 1 diabetes develop diabetic nephropathy long-term (usually not before at least 10 years of diabetes), though this proportion is falling as standards of care have risen. Nephropathy is strongly associated with other microvascular complications of diabetes, so that some degree of retinopathy is to be expected, and evidence of neuropathy is common. Patients with type 2 diabetes are equally susceptible, but this is an older group in which vascular disease and other pathologies are also more likely. The rise in type 2 diabetes accounts for diabetes being the mo

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Jr, John F. Keaney. Oxidative Stress and Vascular Disease (Developments in Cardiovascular Medicine). Springer, 2000.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Macrovascular Disease in Diabetes Mellitus: Pathogenesis and Prevention (Hormone and Metabolic Research. Supplement Series, Vol 15). Thieme Medical Pub, 1986.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Chakera, Aron, William G. Herrington, and Christopher A. O’Callaghan. Screening for kidney disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0353.

Повний текст джерела

Анотація:

Renal disease is common and, with routine reporting of estimated glomerular filtration rates, impairment of renal function is increasingly being recognized. As renal impairment is usually asymptomatic until very advanced, chronic kidney disease (CKD) guidelines have been developed to improve the identification and screening of at-risk populations. Target groups include patients with vascular risk factors (e.g. diabetes mellitus and hypertension); patients with certain multisystem diseases which can cause renal impairment; patients with urological conditions; patients on nephrotoxic medication;

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Almedawar, Mohamad M., Richard C. Siow, and Henning Morawietz. MicroRNAs as novel biomarkers in depression, diabetes, and cardiovascular diseases. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198789284.003.0003.

Повний текст джерела

Анотація:

Diabetic, depressive, and cardiovascular disorders are leading causes of morbidity. In diabetics, symptoms of depression are associated with increased clinical complications. Diabetes mellitus is a major risk factor of cardiovascular diseases (CVDs). The vascular depression hypothesis suggests that CVD can increase the risk of depression or exacerbate depression-related conditions. Several studies found a strong correlation between depression and pre-existing vascular disease and vice versa. Recent studies implicate microvascular dysfunction in the pathophysiology of depression and CVD. In add

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Ferro, José M., and Ana Catarina Fonseca. Secondary prevention. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198722366.003.0015.

Повний текст джерела

Анотація:

There are no specific guidelines regarding secondary stroke prevention in young adult stroke patients. Recommendations for secondary prevention are mainly extrapolated from data obtained from older individuals, because young adults were excluded or under-represented in most secondary stroke prevention clinical trials. Secondary stroke prevention includes (a) screening and control of vascular risk factors, that is, hypertension, diabetes mellitus, hyperlipidaemia, atrial fibrillation, hormonal contraception, infections, trauma, physical inactivity, obesity, poor nutrition, smoking, alcohol, and

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Doumas, Michael, and Chrysoula Boutari. Erectile dysfunction: definition and size of the problem. Edited by Charalambos Vlachopoulos. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198784906.003.0243.

Повний текст джерела

Анотація:

Erectile dysfunction is currently considered a manifestation of vascular disease in the majority of cases. It is therefore of no surprise that erectile dysfunction is commonly found in patients with overt cardiovascular disease and/or cardiovascular risk factors. Indeed, more than 50% of patients with stable coronary artery disease or acute coronary syndromes suffer from erectile dysfunction, while the prevalence of erectile dysfunction in patients with heart failure is even higher. Likewise, erectile dysfunction is frequently encountered in patients with arterial hypertension, diabetes mellit

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Schmid, Jean-Paul, and Hugo Saner. Ambulatory preventive care: outpatient clinics and primary care. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656653.003.0023.

Повний текст джерела

Анотація:

Cardiac rehabilitation (CR) services aim to restore the physical, psychosocial, and vocational status of cardiac patients. The role of these services has evolved due to the progress of interventional cardiology with its prompt and effective treatment of acute coronary syndromes. The focus has moved from the restoration of a patient’s health following an acute event towards a more pronounced long-term targeted secondary prevention intervention. As a consequence, CR services have also expanded their indication in order to include not only patients after myocardial infarction or surgery but also

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Schmid, Jean-Paul, Hugo Saner, Paul Dendale, and Ines Frederix. Ambulatory preventive care: outpatient clinics and primary care. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199656653.003.0023_update_001.

Повний текст джерела

Анотація:

Cardiac rehabilitation (CR) services aim to restore the physical, psychosocial, and vocational status of cardiac patients. The role of these services has evolved due to the progress of interventional cardiology with its prompt and effective treatment of acute coronary syndromes. The focus has moved from the restoration of a patient’s health following an acute event towards a more pronounced long-term targeted secondary prevention intervention. As a consequence, CR services have also expanded their indication in order to include not only patients after myocardial infarction or surgery but also

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Farmakis, Dimitrios, John Parissis, and Gerasimos Filippatos. Acute heart failure: epidemiology, classification, and pathophysiology. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0051.

Повний текст джерела

Анотація:

Acute heart failure is defined as the rapid development or change of symptoms and signs of heart failure that requires urgent medical attention and usually hospitalization. Acute heart failure is the first reason for hospital admission in individuals aged 65 or more and accounts for nearly 70% of the total health care expenditure for heart failure. It is characterized by an adverse prognosis, with an in-hospital mortality rate of 4-7%, a 2-3-month post-discharge mortality of 7-11%, and a 2-3-month readmission rate of 25-30%. The majority of patients have a previous history of heart failure and

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!